Physicians Financial Services Inc. Has $709,000 Stock Position in Starbucks Co. (NASDAQ:SBUX)

Physicians Financial Services Inc. lessened its stake in Starbucks Co. (NASDAQ:SBUX) by 1.9% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 7,770 shares of the coffee company’s stock after selling 151 shares during the quarter. Physicians Financial Services Inc.’s holdings in Starbucks were worth $709,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. Financial Life Planners acquired a new stake in Starbucks in the fourth quarter valued at $25,000. Collier Financial bought a new stake in shares of Starbucks in the 4th quarter valued at about $27,000. Centricity Wealth Management LLC acquired a new stake in Starbucks in the 4th quarter valued at about $36,000. DT Investment Partners LLC grew its holdings in Starbucks by 39.4% during the third quarter. DT Investment Partners LLC now owns 428 shares of the coffee company’s stock worth $42,000 after purchasing an additional 121 shares during the period. Finally, Morton Brown Family Wealth LLC increased its position in Starbucks by 43.9% during the fourth quarter. Morton Brown Family Wealth LLC now owns 505 shares of the coffee company’s stock worth $46,000 after buying an additional 154 shares during the last quarter. 72.29% of the stock is owned by institutional investors.

Starbucks Stock Up 0.8 %

SBUX opened at $113.34 on Friday. Starbucks Co. has a twelve month low of $71.55 and a twelve month high of $113.50. The stock has a market capitalization of $128.74 billion, a price-to-earnings ratio of 36.56, a P/E/G ratio of 3.56 and a beta of 1.00. The company has a 50-day simple moving average of $99.44 and a 200 day simple moving average of $96.89.

Starbucks (NASDAQ:SBUX) last posted its quarterly earnings results on Tuesday, January 28th. The coffee company reported $0.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.68 by $0.01. Starbucks had a net margin of 9.73% and a negative return on equity of 44.97%. During the same quarter last year, the business posted $0.90 EPS. Sell-side analysts anticipate that Starbucks Co. will post 2.99 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently issued reports on SBUX shares. Stifel Nicolaus raised their price objective on Starbucks from $110.00 to $114.00 and gave the company a “buy” rating in a research report on Monday, January 27th. BMO Capital Markets lifted their price objective on shares of Starbucks from $110.00 to $115.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 29th. Barclays increased their price objective on shares of Starbucks from $119.00 to $124.00 and gave the company an “overweight” rating in a research report on Wednesday, January 29th. Citigroup raised their target price on shares of Starbucks from $96.00 to $99.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $115.00 price target on shares of Starbucks in a research note on Friday, January 24th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $105.33.

About Starbucks

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items.